I am a recent Ph.D. graduate specialized in molecular signaling pathways in resistance of cancer to anti-cancer therapies. Interested in boosting the body's natural immune system and tumor suppressor genes to fight cancer in the field of oncology. I work with a multi-disciplinary preclinical and translational team at the Stephenson Cancer Center (SCC). Stratifying cancer patients based on genetic mutations to receive the right targeted therapy. Based on critical molecular signaling, driven to ultimately develop and translate therapeutics for cancer to overcome resistance and improve the efficacy and safety profiles of existing and emerging therapeutics.